FRI used to understand the link between pulmonary vasculature abnormalities and DCLO in COVID-19 In a recent article, Prof Daniel Salerno, Prof Victor Kim and colleagues used Functional Respiratory Imaging to better understand the crucial... View Article
In a recent published study Functional Respiratory Imaging (FRI) was used to assess Mandibular advancement devices (MAD) mechanisms. MAD are a non-invasive treatment option for patients with obstructive sleep apnea... View Article
FLUIDDA is the world leader in the field of Functional Respiratory Imaging. This technique combines HRCT scans and Computational Fluid Dynamics technology, enabling the assessment of treatment responses, and helping physicians to make... View Article
In a recent publication in CHEST Journal, the importance of the small airways and their contribution to symptoms of asthma and COPD are discussed. Significant small airways dysfunction can be found... View Article
Fluidda’s vascular lung images featured on the cover of the digital European Respiratory Journal The European Respiratory Journal published a study (ERJ, impact factor 16.67) looking at the pulmonary blood... View Article
Healthcare Tech Outlook, a leading Healthcare technology print magazine, which provides a knowledge network for Healthcare Industry experts, awarded Fluidda as a “Top Ten” Medical Imaging Provider of the year... View Article
A well powered study with FRI as primary endpoint shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations. A recent paper, published in the Int. Journal of Chronic Obstructive... View Article
We supported the Respiratory Health campaign that launched on Launch Date within the Guardian newspaper and online at https://bit.ly/3q3yTG6. Respiratory Health looked at key respiratory conditions, new innovations and the... View Article
In March 2020 Fluidda’s medical device called Broncholab was introduced in the USA. It is a diagnostic support tool to detect and to to improve therapy of lung diseases based on FRI technology. Broncholab will initially... View Article
Dr. Muhunthan Thillai is a pulmonologist at Cambridge University, specialized in pulmonary fibrosis; and co-founder and CEO of Qur8, an imaging platform for analyzing large clinical sets of data. He is... View Article